Should Silicon Valley really be worried about ‘mass exodus’?
Business Insider columnist Adam Lashinsky discusses the trend of tech companies leaving Silicon Valley and says people may be making a bigger deal out of it than it really is.
How doctors can reassure patients about COVID-19 vaccine
Family and emergency medicine expert Dr. Janette Nesheiwat says doctors can address patient hesitancy about taking the coronavirus vaccine by listening to their questions and promoting vaccine education and awareness.
Would you buy a gift you couldn't see to help find a cure for blindness?
Two Blind Brothers founders Bradford and Bryan Manning explain the idea behind their ‘Shop Blind’ challenge, which gives 100 percent of profits to the Foundation Fighting Blindness.
Ex-Microsoft COO on Silicon Valley exodus: 'They brought a lot of this on themselves'
Former Microsoft COO Bob Herbold argues tech companies are moving out of California because of high taxes, the coronavirus pandemic and the realization that employees can work remotely.
Wilbur Ross: Cyberattack on US Treasury, Commerce Dept. taken 'very seriously'
The cyber hack backed by a foreign government on the U.S. Treasury Department and an agency within the Commerce Department is being taken “very seriously,” Commerce Secretary Wilbur Ross said.
Despite COVID-19 vaccine news, it’s not time to back off restrictions: Doctor
AdventHealth Orlando SVP and chief scientific officer Dr. Steven R. Smith gives an update on coronavirus vaccine distribution in Florida.
UK, Canada able to approve coronavirus vaccine because of trials Americans were part of: Alyssa Farah
Former White House Communications Director Alyssa Farah on media coverage of President Trump, the upcoming Senate races in Georgia, Operation Warp Speed and distribution of the coronavirus vaccine.
Azar: Coronavirus vaccination experience will look a lot like getting flu shot
Health and Human Services Secretary Alex Azar breaks down the coronavirus vaccine distribution process and timeline.
Can Disney+ overtake Netflix by 2024?
Jeff Sica of Circle Squared Alternative Investments argues Disney+ will overtake Netflix in the coming years.
Tesla offering free supercharging to Model 3 and Y buyers in year-end sales push
Tesla is incentivizing year-end sales of its Model 3 and Y by including one year of free supercharging. The offer only applies to cars purchased from inventory, however.
As Pfizer’s Covid-19 vaccine rolls out, next step is getting people to take it
Overall, 63% of Americans would be willing to receive an FDA-approved Covid-19 vaccine, according to a Gallup poll released earlier this month that surveyed about 3,000 people.
New York City business owners haunted by Amazon loss amid pandemic
Two years after Amazon pulled out from a proposal to build a massive headquarters along the Queens waterfront, the site is a vacant eyesore — and, to many locals, the squandered economic opportunity is even more painful amid the coronavirus pandemic.
White House confirms cyberattack report on U.S. Treasury by foreign government
“The United States government is aware of these reports and we are taking all necessary steps to identify and remedy any possible issues related to this situation,” National Security Council spokesman John Ullyot told FOX Business in a statement.
Ex-Facebook exec suggests everyone who gets vaccinated should wear certain color mask
Palihapitiya's idea saw a mixed reaction, with some on Twitter comparing it to Nazi Germany's use of the Star of David, while others simply questioned why a mask should still be used when vaccines offer their own protection.
Holiday photo card industry pivots in coronavirus pandemic
Holiday cards might look a little different after the COVID-19 pandemic filled 2020 with surreal, and sometimes terrifying, events.
US says COVID-19 vaccine to start arriving in states Monday
Trucks will roll out Sunday morning as shipping companies UPS and FedEx begin delivering Pfizer’s vaccine to nearly 150 locations.
AstraZeneca to buy Alexion for $39 billion to expand in immunology
Britain’s AstraZeneca has agreed to buy U.S. drugmaker Alexion Pharmaceuticals for $39 billion in cash and shares to bolster its positions in immunology and rare diseases.
COVID-19 vaccine makers turn to testing children
Health experts urge more research to help curb transmission and to reopen schools.
How Pfizer delivered a COVID vaccine in record time: Crazy deadlines, a pushy CEO
Albert Bourla and his team overcame unproven science and manufacturing bottlenecks; ‘you’re asking for too much.’
Facebook's Sandberg jabs government over antitrust lawsuits
Officials have accused Facebook of using its wealth to squelch competition by buying rival social media platforms.